This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Earnings Stocks Poised to Pop

Bacterin International

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

One potential earnings short-squeeze candidate in the medical equipment and supplies sector is Bacterin International (BONE), which is set to report results on Thursday after the market close. This company develops, manufactures and markets biologics products to domestic and international markets through Bacterin's biologics division. Wall Street analysts, on average, expect Bacterin International to report revenue of $9.50 million on a loss of 3 cents per share.

If you're looking for a small-cap stock that's trading within range of triggering a big breakout post-earnings, then make sure to check out shares of Bacterin International. During the last six months, this stock has been on fire rising over 70%.

The current short interest as a percentage of the float for Bacterin International sits at 4.2%. That means that out of the 22.55 million shares in the tradable float, 992,694 shares are sold short by the bears. This isn't a huge short interest, but the float is small so any bullish earnings news could easily spark a big short-squeeze for BONE.

>>10 Small-Cap Stocks Poised to Rise

From a technical perspective, BONE is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the past number of months, rising from $1.73 to its recent high of $3.54 a share. During that uptrend, shares of BONE have consistently made higher lows and higher highs, which is bullish price action. Now the stock is trading within range of triggering a near-term breakout trade.

If you're bullish on BONE, I would wait until after its report and look for long-biased trades if the stock breaks out above some near-term overhead resistance at $3.54 a share with high-volume. Look for volume on that move that's near or well above its three-month average volume of 259,102 shares. If we get that action, then look for BONE to make a run at its November high of $3.93 a share, or possibly towards $4.50 to $4.90 a share, which are past overhead resistance levels.

I would avoid long-biased trades in BONE if this stock fails to break out over $3.65 a share with volume post-earnings. A failure to trigger that breakout could set this stock up to re-test its 50-day moving average of $2.87 or possibly fall lower if the bears slam this stock post-earnings.

3 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs